Sep 2026· PLOS Global Public Health· Vol 6· 0 citations· 189 references
Medicine
TL;DR
A sparse but growing literature of economic evaluations related to vaccine interventions in Africa is identified, with only a handful of countries represented in the articles published, implying a very low production of (and likely a low demand for) economic evaluation evidence.
Abstract
Economic evaluation offers policy makers a valuable tool for optimizing the use scarce healthcare resources. This scoping review aims to describe the existing scientific literature on economic evaluation and budget impact analysis of vaccine interventions, and the use of economic evidence in Africa. It highlights the current landscape and the challenges in using economic data to support vaccine policy on the continent. This study adapted and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. We included peer-reviewed studies published in English between January 2000 and July 2025 that reported on cost and economic evaluations of vaccines administered to children and youth, or on the use of economic evidence for policy decision-making in Africa. A literature search was conducted across five electronic databases: Medline, Embase, Web of Science, and Scopus. The search yielded 4037 articles in total after deduction of duplication. A total of 140 articles were included in the study following title, abstract screening and full text review. The review identified a sparse but growing literature of economic evaluations related to vaccine interventions in Africa. Only a handful of countries are represented in the articles published, implying a very low production of (and likely a low demand for) economic evaluation evidence. Authorship of the articles is led mostly by researchers from institutions based outside Africa, mostly in North America and Europe. Funding of studies is mostly by Gates Foundation, Gavi, PATH, Wellcome Trust and World Health Organisation. Production and use of economic evaluation for vaccine policy in Africa have been hampered by capacity limitations in both research and policy institutions on the continent. The use of the evidence in decision making is limited. In the sphere of vaccine policy, economic evaluation is still a fledging enterprise requiring more investment.
OBJECTIVES
No comprehensive global review has synthesized mechanisms, strengths, limitations, and implementation challenges of pharmaceutical pricing policies. This scoping review aimed to examine global pharmaceutical pricing policies and generate policy-relevant insights, particularly for low- and middle-income count...
Lan Gao, Shu-Chuen Li· Value in Health Regional Iss...· 0 citations
An updated global overview of national HEE guidelines is provided, highlighting areas of convergence in analytical methods, evidence requirements, and approaches to uncertainty and noting persistent differences across countries and income settings.
Thu Anh Do, Ho-Ang Tung· Pharmaceutical Medicine· 0 citations
Economic evaluations of immunisation programmes continue to underrepresent the full multidimensional value of vaccination, with limited incorporation of broader social, economic, and life-course impacts.
L. Prendergast, Emma Begley, Morgan Savoury et al.· Vaccine· 0 citations
Abstract Introduction Economic evaluations conducted alongside clinical trials play a key role in informing healthcare decision-making. While structured validation frameworks are well established for model-based economic evaluations, there is no agreed approach to validating trial-based economic evaluations. Validation...
M. Png, K. Khan, Tracey H. Sach et al.· BMJ Open· 0 citations
Malaria remains a severe public health crisis in Africa, causing 94% of global cases and 95% of deaths in 2023. While the rollout of the RTS, S/AS01 and R21/Matrix-M vaccines marks a historic shift, long-term public health success relies on adult acceptance particularly among parents, caregivers, and healthcare workers...
Clinton Kwemu Njakoi, Carine Njwengba Owajege, Frankline Sevidzem Wirsiy· Discover Public Health· 0 citations
The findings were mixed but frequently favorable: several teleconsultation, teledermatology, telestroke, and teletherapy interventions were cost-saving or dominant, whereas home telemonitoring for chronic disease was often not cost-effective at conventional thresholds.
Dimvy Rusefani, Asetya· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.